Rebound Hyperglycemia

Rebound Hyperglycemia is a physiological phenomenon in the context of hypoglycemic drug toxicity characterized by an acute elevation in blood glucose levels following an episode of hypoglycemia, resulting from counterregulatory hormone responses that overshoot normal glycemic regulation.

54

Publications

3K

Citations

259

Authors

99

Institutions

Publications per year

2017–2026

8

Variants

Somogyi EffectSomogyi Phenomenon

Authors

259

  1. JE
    John E. Gerich

    Mayo Clinic, United States

    2 publications · 256 citations

    2

    h-index

  2. MW
    Morey W. Haymond

    Mayo Clinic, United States

    2 publications · 256 citations

    2

    h-index

  3. GB
    Geremia B. Bolli

    University of Perugia, Italy

    2 publications · 256 citations

    2

    h-index

  4. PE
    Philip E. Cryer

    Washington University in St. Louis, United States

    2 publications · 256 citations

    2

    h-index

  5. BA
    Bruce A. Buckingham

    Stanford University, United States

    2 publications · 269 citations

    2

    h-index

1–5 of 259

Venues

  1. Diabetes Technology & Therapeutics

    4 publications · 321 citations

    4

    h-index

  2. Endocrine Practice

    2 publications · 278 citations

    2

    h-index

  3. Journal of Clinical Anesthesia

    JCA · 2 publications · 73 citations

    2

    h-index

  4. PubMed

    Repository · 2 publications · 41 citations

    2

    h-index

  5. Pediatric Cardiology

    2 publications · 85 citations

    2

    h-index

1–5